TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
127 hedge funds and large institutions have $211M invested in Tvardi Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
+6
Holders Change %
+4.96%
% of All Funds
2.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
28
Reduced
39
Closed
21
Calls
$4.36M
Puts
$6.24M
Net Calls
-$1.88M
Net Calls Change
+$2.45M
Top Buyers
| 1 |
BlackRock
New York
|
+$5.5M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.34M |
| 3 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$1.63M |
| 4 |
First Manhattan
New York
|
+$1.25M |
| 5 |
Millennium Management
New York
|
+$1.14M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$20M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.48M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$3.19M |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$2.12M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.95M |
